Fluorescent Imaging in Medicinal Chemistry
278,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
139 °P sammeln
  • Gebundenes Buch

This book reviews the most recent developments of fluorescent imaging techniques for medicinal chemistry research and biomedical applications, including cell imaging, in vitro diagnosis and in vivo imaging.
Fluorescent imaging techniques play an important role in basic research, drug discovery and clinical translation. They have great impact to many fields including chemical biology, cell biology, medical imaging, cancer diagnosis and treatment, pharmaceutical science, among others, and they have facilitated our understanding of diseases and helped to develop many novel powerful tools for…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book reviews the most recent developments of fluorescent imaging techniques for medicinal chemistry research and biomedical applications, including cell imaging, in vitro diagnosis and in vivo imaging.

Fluorescent imaging techniques play an important role in basic research, drug discovery and clinical translation. They have great impact to many fields including chemical biology, cell biology, medical imaging, cancer diagnosis and treatment, pharmaceutical science, among others, and they have facilitated our understanding of diseases and helped to develop many novel powerful tools for imaging and treatment of diseases.

This book will appeal to scientists from numerous fields such as chemistry, pharmaceutical science, biology, materials science, and medicine, and it will serve as a very useful and handy resource for readers with different levels of scientific knowledge, ranging from entry level to professional level.

Autorenporträt
Dr. Zhen Cheng is Associate Professor of Radiology and a member of the Molecular Imaging Program at Stanford (MIPS), BioX program, Canary Center at Stanford for Cancer Early Detection, and Stanford Cancer Center. He currently leads the Cancer Molecular Imaging Chemistry Laboratory (CMICL) of the MIPS, where he is developing novel molecular probes, non-invasive imaging techniques and bionanotechnology for the early detection and treatment of cancer. Dr. Cheng earned his PhD in Chemistry from University of Missouri-Columbia in 2001 and completed his post-doc training at Harvard Medical School in 2003. Dr. Cheng has published over 200 peer-reviewed articles. He has served as a reviewer for several funding agencies including NIH, DOD, DOE, etc. and also as an active reviewer for over 100 research journals.